Swiss Life Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Swiss Life Asset Management’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$290K	Buy	+3,018	New	+$309K	﹤0.01%	1288

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Swiss Life Asset Management's LMAT Position: Q2 2026 in Review

Swiss Life Asset Management opened a new position in LeMaitre Vascular (LMAT) in Q2 2026: 3,018 shares worth $290K. The stake represents ﹤0.01% of the portfolio and ranks #1288 among its holdings.

212 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Swiss Life Asset Management held 3,018 shares of LeMaitre Vascular worth $290K as of Q2 2026.
LeMaitre Vascular was a new Swiss Life Asset Management position in Q2 2026.
LeMaitre Vascular made up ﹤0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #1288 holding.
212 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.